title: Role of oncogene 24p3 neutrophil gelatinase-associated lipocalin (NGAL) in digestive system cancers.
abstract: Neutrophil gelatinase-associated lipocalin, known also as 24p3 lipocalin, lipocalin-2 or uterocalin (in mouse), is a small secretory protein binding small molecular weight ligands which takes part in numerous processes including apoptosis induction in leukocytes, iron transport, smell, and prostaglandins and retinol transport [19]. It was discovered in activated neutrophils as a covalent peptide associated with human gelatinase neutrophils [7]. Neutrophil lipocalin is secreted physiologically in the digestive system, respiratory tract, renal tubular cells, liver or immunity system. Systematic (circulated in plasma) neutrophil gelatinase come from multiple sources; it may be synthesized in the liver, secreted from activated neutrophils or macrophages, or derive from atherosclerosis or inflammatory endothelial cells [17]. NGAL is stored secondarily in granulates with lactoferrin, calprotectin or MAC-1, which take part in neutrophils' action and migration [13,19]. NGAL participates in acute and chronic inflammation (production of NGAL is indicated by factors conducive to cancer progression) [13,21]. NGAL levels increase in inflammatory or endothelial damage. NGAL level is measured in blood or urine. It is known as a kidney failure factor [7,20]. NGAL is therefore one of the most promising new generation biomarkers in clinical nephrology [6]. The role of NGAL in digestive system neoplasms has not been explored in detail. However, overexpression of this marker was proved in neoplasms such as esophageal carcinoma, stomach cancer, pancreatic cancer or colon cancer, which may indicate an association between concentration and neoplasm [3].
authors.affiliation: Klinika Nefrologii, Nadciśnienia Tętniczego i Medycyny Rodzinnej USK im. WAM-CSW.
authors.forename: Łukasz
authors.initials: Ł
authors.lastname: Michalak
authors.affiliation: Zakład Biofarmacji Katedra Biofarmacji UM w Łodzi.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Bulska
authors.affiliation: Zakład Biofarmacji Katedra Biofarmacji UM w Łodzi.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Kudłacz
authors.affiliation: Zakład Biofarmacji Katedra Biofarmacji UM w Łodzi.
authors.forename: Piotr
authors.initials: P
authors.lastname: Szcześniak
mesh_terms: D004067:Digestive System Neoplasms / Q000235:genetics* / Q000503:physiopathology*; D006801:Humans; D000071068:Lipocalin-2 / Q000235:genetics* / Q000378:metabolism*
chemical_list: D000071068:Lipocalin-2